Ballicules.com

Ivabradine

CORLANOR

What it isSelective funny-current inhibitor in the sinus node; heart failure and inappropriate sinus tachycardia.

Why this oneIt slows the heart without lowering blood pressure or contractility, so it works when beta blockade is maximal or not tolerated.

What limits itFetal toxicity, and it only works in sinus rhythm. Luminous phenomena; CYP3A4-dependent.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Stable symptomatic heart failure (reduce hospitalization)Adult5 mg BID (2.5 mg BID if vulnerable or conduction defect)titrate to resting HR 50-60 bpm7.5 mg BID

Titration Reassess after 2 weeks, then adjust by 2.5 mg BID based on resting heart rate.

Renal No adjustment for CrCl ≥15 mL/min; no data if CrCl <15 mL/min.

Hepatic No adjustment in mild-moderate impairment; contraindicated in severe (Child-Pugh C).

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy May cause fetal harm (cardiac teratogenicity in animals); advise effective contraception.

Lactation Undefined

NO BOXED WARNINGS

Principal riskFetal toxicity; it works only in sinus rhythm

Cost, est. cash$300–$2,500/month

Generic entry2021

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades3 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Ivabradine ballicule

Ivabradine ballicule: receptor binding, kinetics and half-life diagram

Open Ivabradine in the interactive console ↗

Memory aids: mascots and interaction avatars

Ivabradine CORLANOR mascot mnemonic cartoon
“Ivy braids in Coral”
Ivabradine CYP3A4 substrate avatar
CYP3A4 substrate

Open Ivabradine in the interactive console ↗